{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:55:50Z","timestamp":1793404550275,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022656","name":"Centre Hospitalier Universitaire de N\u00eemes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022656","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioflm.2026.100375","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:54:47Z","timestamp":1781542487000},"page":"100375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics"],"prefix":"10.1016","volume":"12","author":[{"given":"Vincent","family":"Jean-Pierre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Sorlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dunyach-Remy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Salipante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Pouget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2130-6335","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Marchandin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2026.100375_bib1","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/apm.12686","article-title":"A short history of microbial biofilms and biofilm infections","volume":"125","author":"H\u00f8iby","year":"2017","journal-title":"APMIS"},{"key":"10.1016\/j.bioflm.2026.100375_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antibiotics9020059","article-title":"Bacterial biofilm and its role in the pathogenesis of disease","volume":"9","author":"Vestby","year":"2020","journal-title":"Antibiotics"},{"issue":"203","key":"10.1016\/j.bioflm.2026.100375_bib3","article-title":"Biofilms and their role on diseases","volume":"23","author":"Gondil","year":"2023","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1099\/00207713-24-4-470","article-title":"Description of Achromobacter xylosoxidans Yabuuchi and Ohyama 1971","volume":"24","author":"Yabuuchi","year":"1974","journal-title":"Int J Syst Bacteriol"},{"key":"10.1016\/j.bioflm.2026.100375_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3390\/genes12050610","article-title":"Achromobacter xylosoxidans and Stenotrophomonas maltophilia: emerging pathogens well-armed for life in the cystic fibrosis patients' lung","volume":"12","author":"Menetrey","year":"2021","journal-title":"Genes"},{"key":"10.1016\/j.bioflm.2026.100375_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/microorganisms4030033","article-title":"Achromobacter species isolated from cystic fibrosis patients reveal distinctly different biofilm morphotypes","volume":"4","author":"Nielsen","year":"2016","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioflm.2026.100375_bib7","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1017\/S0950268816001564","article-title":"Achromobacter xylosoxidans is the predominant Achromobacter species isolated from diverse non-respiratory samples","volume":"144","author":"Amoureux","year":"2016","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bioflm.2026.100375_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jcf.2015.12.009","article-title":"Distribution of the species of Achromobacter in a French cystic fibrosis centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates","volume":"15","author":"Amoureux","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100375_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02953-23","article-title":"Prevalence and variability of siderophore production in the Achromobacter genus","volume":"12","author":"Sorlin","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.bioflm.2026.100375_bib10","doi-asserted-by":"crossref","first-page":"e00724","DOI":"10.1128\/jcm.00724-25","article-title":"Clinical and microbiologic features of Achromobacter species: a 10-year, multicenter experience","volume":"63","author":"Bayless","year":"2025","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fcimb.2017.00224","article-title":"Uncovering differences in virulence markers associated with Achromobacter species of CF and non-CF origin","volume":"7","author":"Filipic","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","article-title":"Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci","volume":"115","author":"Stepanovi\u0107","year":"2007","journal-title":"APMIS"},{"key":"10.1016\/j.bioflm.2026.100375_bib13","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3390\/diagnostics11101746","article-title":"New adapted in vitro technology to evaluate biofilm formation and antibiotic activity using live imaging under flow conditions","volume":"11","author":"Pouget","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.bioflm.2026.100375_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01025-20","article-title":"Achromobacter infections and treatment options","volume":"64","author":"Isler","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0034-1396929","article-title":"Stenotrophomonas, Achromobacter, and nonmelioid Burkholderia species: antimicrobial resistance and therapeutic strategies","volume":"36","author":"Abbott","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.bioflm.2026.100375_bib16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/phar.2447","article-title":"An overview of the treatment of less common non\u2013lactose\u2010fermenting gram\u2010negative bacteria","volume":"40","author":"Spencer","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bioflm.2026.100375_bib17","doi-asserted-by":"crossref","first-page":"e02911","DOI":"10.1128\/JCM.02911-20","article-title":"Transmission and antibiotic resistance of Achromobacter in cystic fibrosis","volume":"59","author":"Gabrielaite","year":"2021","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib18","series-title":"CA-SFM\/EUCAST. Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","article-title":"Achromobacter xylosoxidans, p 69","year":"2025"},{"key":"10.1016\/j.bioflm.2026.100375_bib19","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.3390\/ijms23169265","article-title":"Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance","volume":"23","author":"Sandri","year":"2022","journal-title":"IJMS"},{"key":"10.1016\/j.bioflm.2026.100375_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12941-024-00709-z","article-title":"Cefiderocol susceptibility of Achromobacter spp.: study of an accurately identified collection of 230 strains","volume":"23","author":"Jean-Pierre","year":"2024","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.bioflm.2026.100375_bib21","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/mdr.2023.0301","article-title":"Drug resistance in biofilm and planktonic cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia clinical isolates","volume":"30","author":"Montoya-Hinojosa","year":"2024","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.bioflm.2026.100375_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmm.2025.151664","article-title":"Biofilm-associated Achromobacter xylosoxidans prosthetic valve infective endocarditis","volume":"320","author":"Wackernagel","year":"2025","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.mimet.2006.11.010","article-title":"A new device for rapid evaluation of biofilm formation potential by bacteria","volume":"68","author":"Chavant","year":"2007","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.bioflm.2026.100375_bib24","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1128\/AEM.03065-09","article-title":"New device for high-throughput viability screening of flow biofilms","volume":"76","author":"Benoit","year":"2010","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib25","series-title":"EUCAST","year":"2026"},{"key":"10.1016\/j.bioflm.2026.100375_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.00264-25","article-title":"Defining antimicrobial susceptibility testing methods and breakpoints among Achromobacter species","volume":"63","author":"Harris","year":"2025","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.750489","article-title":"Biofilm formation in methicillin-resistant Staphylococcus aureus isolated in cystic fibrosis patients is strain-dependent and differentially influenced by antibiotics","volume":"12","author":"Boudet","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/jac\/dkac438","article-title":"Antimicrobial activity of antibiotics on biofilm formed by Staphylococcus aureus and Pseudomonas aeruginosa in an open microfluidic model mimicking the diabetic foot environment","volume":"78","author":"Pouget","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib29","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v099.i15","article-title":"Permutation tests for regression, ANOVA, and comparison of signals: the permuco package","volume":"99","author":"Frossard","year":"2021","journal-title":"J Stat Software"},{"key":"10.1016\/j.bioflm.2026.100375_bib30","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/00031305.1980.10483031","article-title":"Population marginal means in the linear model: an alternative to least squares means","volume":"34","author":"Searle","year":"1980","journal-title":"Am Statistician"},{"key":"10.1016\/j.bioflm.2026.100375_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2014.00138","article-title":"Outbreak of Achromobacter xylosoxidans in an Italian cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains","volume":"5","author":"Trancassini","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136790","article-title":"Genetic adaptation of Achromobacter sp. during persistence in the lungs of cystic fibrosis patients","volume":"10","author":"Ridderberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bioflm.2026.100375_bib33","first-page":"98","article-title":"Achromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: case reports","volume":"20","author":"Firmida","year":"2017","journal-title":"Respiratory Med Case Rep"},{"key":"10.1016\/j.bioflm.2026.100375_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/pathogens6020020","article-title":"Differences in gene expression profiles between early and late isolates in monospecies Achromobacter biofilm","volume":"6","author":"Nielsen","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.bioflm.2026.100375_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/pathogens9020072","article-title":"Hypermutation as an evolutionary mechanism for Achromobacter xylosoxidans in cystic fibrosis lung infection","volume":"9","author":"Veschetti","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.bioflm.2026.100375_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00523-21","article-title":"Genomic and phenotypic evolution of Achromobacter xylosoxidans during chronic airway infections of patients with cystic fibrosis","volume":"6","author":"Khademi","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.bioflm.2026.100375_bib37","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/pathogens10080978","article-title":"Adaptive interactions of Achromobacter spp. with Pseudomonas aeruginosa in cystic fibrosis chronic lung co-infection","volume":"10","author":"Sandri","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.bioflm.2026.100375_bib38","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002051","article-title":"The cystic fibrosis pathogen Achromobacter xylosoxidans inhibits biofilm formation of Pseudomonas aeruginosa","volume":"74","author":"Sahl","year":"2025","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib39","article-title":"Hospital acquired pneumonia due to Achromobacter spp. in a geriatric ward in China: clinical characteristic, genome variability, biofilm production, antibiotic resistance and integron in isolated strains","volume":"7","author":"Liu","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib40","series-title":"Effects of genetic and environmental variables on biofilm development dynamics in Achromobacter mucicolens","author":"Al-Kahachi","year":"2023"},{"key":"10.1016\/j.bioflm.2026.100375_bib41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12223-024-01182-z","article-title":"Antibacterial activity of gallic acid and methyl gallate against emerging non-fermenting bacilli","volume":"70","author":"Flores-Maldonado","year":"2025","journal-title":"Folia Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2014.07.012","article-title":"Achromobacter bacteraemia outbreak in a paediatric onco-haematology department related to strain with high surviving ability in contaminated disinfectant atomizers","volume":"89","author":"Hugon","year":"2015","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.bioflm.2026.100375_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/trstmh\/trz109","article-title":"Achromobacter xylosoxidans in hospital environments: still waters run deep","volume":"114","author":"Marion-Sanchez","year":"2020","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.bioflm.2026.100375_bib44","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13205-020-02459-z","article-title":"Bacillus subtilis TR47II as a source of bioactive lipopeptides against Gram-negative pathogens causing nosocomial infections","volume":"10","author":"De Souza Freitas","year":"2020","journal-title":"3 Biotech"},{"key":"10.1016\/j.bioflm.2026.100375_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2025.116797","article-title":"Achromobacter xylosoxidans: an uncommon scalp infection leading to alopecia and biofilm formation","volume":"112","author":"Wan","year":"2025","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100375_bib46","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3201\/eid1407.070894","article-title":"Alcaligenes xylosoxidans bloodstream infections in outpatient oncology office","volume":"14","author":"Kim","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100375_bib47","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1167\/iovs.11-8762","article-title":"Bacterial biofilm diversity in contact lens-related disease: emerging role of Achromobacter, Stenotrophomonas, and Delftia","volume":"53","author":"Wiley","year":"2012","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.bioflm.2026.100375_bib48","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1097\/ICL.0000000000000425","article-title":"Adhesion of Stenotrophomonas maltophilia, Delftia acidovorans, and Achromobacter xylosoxidans to contact lenses","volume":"44","author":"Vijay","year":"2018","journal-title":"Eye Contact Lens Sci Clin Pract"},{"key":"10.1016\/j.bioflm.2026.100375_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1556\/030.64.2017.005","article-title":"Biofilm formation of Achromobacter xylosoxidans on contact lens","volume":"64","author":"Konstantinovi\u0107","year":"2017","journal-title":"Acta Microbiol Immunol Hung"},{"key":"10.1016\/j.bioflm.2026.100375_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007811","article-title":"Culture-independent microbiological analysis of Foley urinary catheter biofilms","volume":"4","author":"Frank","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bioflm.2026.100375_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1142274","article-title":"The value of biofilm testing to guide antimicrobial stewardship in chronic respiratory diseases","volume":"13","author":"Fern\u00e1ndez-Barat","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5604\/01.3001.0010.6996","article-title":"Temperature, pH and trimethoprim-sulfamethoxazole are potent inhibitors of biofilm formation by Stenotrophomonas maltophilia clinical isolates","volume":"66","author":"Bio\u010danin","year":"2017","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.bioflm.2026.100375_bib54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/JCM.02938-15","article-title":"The BioFilm ring test: a rapid method for routine analysis of Pseudomonas aeruginosa biofilm formation kinetics","volume":"54","author":"Olivares","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib55","doi-asserted-by":"crossref","first-page":"e02204","DOI":"10.1128\/AAC.02204-19","article-title":"Activity of antibiotics against Pseudomonas aeruginosa in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium","volume":"64","author":"Diaz Iglesias","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","article-title":"The biofilm life cycle: expanding the conceptual model of biofilm formation","volume":"20","author":"Sauer","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00870-25","article-title":"Achromobacter xylosoxidans isolates exhibit genome diversity, variable virulence, high levels of antibiotic resistance, and potential intrahost evolution","volume":"11","author":"Acharya","year":"2026","journal-title":"mSphere"},{"key":"10.1016\/j.bioflm.2026.100375_bib58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.02240-15","article-title":"Effect of high-dose antimicrobials on biofilm growth of Achromobacter species isolated from cystic fibrosis patients","volume":"60","author":"Tom","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib59","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1017\/S0950268816002624","article-title":"Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis","volume":"145","author":"Pereira","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.bioflm.2026.100375_bib60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/1120009X.2020.1819702","article-title":"Antibacterial and antibiofilm activities of ceragenins against Achromobacter species isolated from cystic fibrosis patients","volume":"33","author":"Damar-\u00c7elik","year":"2021","journal-title":"J Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10096-024-05017-0","article-title":"The in vitro synergistic and antibiofilm activity of ceftazidime\/avibactam against Achromobacter species recovered from respiratory samples of cystic fibrosis patients","volume":"44","author":"Matarac\u0131-Kara","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100375_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01194-20","article-title":"Cefiderocol retains antibiofilm activity in multidrug-resistant Gram-negative pathogens","volume":"65","author":"Pybus","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2020.100031","article-title":"Antibiotic susceptibility of cystic fibrosis lung microbiome members in a multispecies biofilm","volume":"2","author":"Vandeplassche","year":"2020","journal-title":"Biofilm"},{"key":"10.1016\/j.bioflm.2026.100375_bib64","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/08927014.2014.944173","article-title":"Interaction between atypical microorganisms and E. coli in catheter-associated urinary tract biofilms","volume":"30","author":"Azevedo","year":"2014","journal-title":"Biofouling"},{"key":"10.1016\/j.bioflm.2026.100375_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.558160","article-title":"High occurrence of bacterial competition among clinically documented opportunistic pathogens including Achromobacter xylosoxidans in cystic fibrosis","volume":"11","author":"Menetrey","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2026.100375_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.115931","article-title":"Effects of four antibiotics on Pseudomonas aeruginosa motility, biofilm formation, and biofilm-specific antibiotic resistance genes expression","volume":"106","author":"Arslan","year":"2023","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100375_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00778-17","article-title":"Subinhibitory concentrations of trimethoprim and sulfamethoxazole prevent biofilm formation by Acinetobacter baumannii through inhibition of Csu pilus expression","volume":"61","author":"Moon","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100375_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106856","article-title":"Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm","volume":"62","author":"Benavent","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bioflm.2026.100375_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/pharmaceutics16010117","article-title":"Antibiotics against Pseudomonas aeruginosa on human skin cell lines: determination of the highest non-cytotoxic concentrations with antibiofilm capacity for wound healing strategies","volume":"16","author":"Qui\u00f1ones-Vico","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioflm.2026.100375_bib70","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ismej.2009.9","article-title":"Siderophore production and biofilm formation as linked social traits","volume":"3","author":"Harrison","year":"2009","journal-title":"ISME J"},{"key":"10.1016\/j.bioflm.2026.100375_bib71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jgar.2024.01.021","article-title":"Evaluation of antibiofilm activity of cefiderocol alone and in combination with imipenem against Pseudomonas aeruginosa","volume":"37","author":"Ferretti","year":"2024","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:22:57Z","timestamp":1790770977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207526000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":71,"alternative-id":["S2590207526000328"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100375","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early and mature Achromobacter xylosoxidans biofilm in cystic fibrosis and non-cystic fibrosis isolates: dynamics and response to clinically relevant antibiotics","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100375"}}